Baxter

Baxter International has named John J. Greisch to the newly created role of corporate vice president and president, International. Mr. Greisch has served as the company’s chief financial officer since 2004 and assumes responsibility for Baxter’s operations outside the U.S. Robert M. Davis, currently the company’s treasurer, succeeds Mr. Greisch as corporate vice president and chief financial officer. Mr. Greisch and Mr. Davis will report to Robert L. Parkinson, Jr., Baxter’s chairman and chief executive officer.

Mr. Greisch joined the company in 2002 as vice president of finance for Baxter’s Renal business. In 2003, he assumed the role of vice president of finance and strategy for Baxter’s BioScience business before being named president of BioScience in January 2004. He was named corporate vice president and chief financial officer in June 2004.

Since his appointment as treasurer in 2004, Mr. Davis has been overseeing Baxter’s global treasury operations, including pension investments, insurance risk management, capital markets and cash management. He will retain his current treasurer responsibilities on an interim basis until a successor is named. Prior to joining the company, Mr. Davis served in a number of financial roles for Eli Lilly and Co., including assistant treasurer, director of corporate financial planning, tax counsel and corporate tax planning.

The company also announced that James E. Utts, president of Baxter Europe since 2004, has decided to retire from the company on August 4. During his career with Baxter, Mr. Utts held a number of senior leadership positions in marketing and general management in the U.S., Canada and Europe.